Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HumaScan

This article was originally published in The Gray Sheet

Executive Summary

Donald Brounstein resigns as president and CEO of the Cranford, New Jersey firm May 19. Since founding the company in 1995, Brounstein managed the development and recent launch of the firm's Breast Alert breast cancer detection device ("The Gray Sheet" Nov. 17, In Brief). Elizabeth Tallett replaces Brounstein on an interim basis as chairman and acting CEO until a permanent replacement is found. Tallett maintains responsibilities as president and CEO of two start-up companies: Dioscor, a biotech management company and Ellard Pharmaceuticals...
UsernamePublicRestriction

Register

MT010160

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel